Senseonics inks CGM data deal with Glooko

Senseonics (NYSE:SENS) said today that data from its Eversense continuous glucose monitoring system can be integrated into Glooko‘s diabetes data management tech. Thanks to the new partnership, Eversense users will be able to view historical glucose trends in Glooko’s mobile and web apps as well as real-time data from the Eversense mobile app, according to Senseonics. Get the full story at our sister site, Drug Delivery Business News. The post Senseonics inks CGM data deal with Glooko appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Big Data Diabetes mHealth (Mobile Health) Wall Street Beat Glooko Senseonics Source Type: news